Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Bassat, Quique ^a,b   González, Raquel ^a,b   MacHevo, Sánia ^b   Nahum, Alain ^c   Lyimo, John ^d   Maiga, Hamma ^e   Mårtensson, Andreas ^f,l   Bashraheil, Mahfudh ^g   Ouma, Peter ^g   Ubben, David ^h   Walter, Verena ⁱ   Nwaiwu, Obiyo ^j   Kipkeu, Chemtai ^k   Lefèvre, Gilbert ⁱ   Ogutu, Bernhards ^g   Menéndez, Clara ^a,b  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b Manhiça Health Research Center   (Mozambique)

^c CENTRE DE RECHERCHE ENTOMOLOGIQUE DE COTONOU CREC   (Benin)

^d IFAKARA HEALTH INSTITUTE   (Tanzania)

^e UNIVERSITY OF BAMAKO   (Mali)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^h Medicines for Malaria Venture MMV   (Switzerland)

ⁱ NOVARTIS PHARMA AG   (Switzerland)

^j Novartis Pharma AG   (Nigeria)

^k Africa Re Center   (Kenya)

^l KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; BENFLUMETOL; DIHYDROARTEMISININ; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

AFRICA; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CHILD; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; HEADACHE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; POPULATION RESEARCH; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING; AGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; PARASITOLOGY; PATHOGENICITY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; TIME;

AGE FACTORS; ANTIMALARIALS; ARTEMISININS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 83455178955     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-369     Document Type: Article

References (30)

1. The public health impact of chloroquine resistance in Africa. Trape JF, Am J Trop Med Hyg 2001 64 1-2 Suppl 12 17 11425173
2. WHO, Guidelines for the treatment of malaria Second World Health Organization web site. [Available at http://www.who.int/malaria/publications/ atoz/9789241547925/en/index.html Accessed March 29, 2010]
3. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomized trial. Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP, Lancet 2005 365 1467 1473 10.1016/S0140- 6736(05)66416-1 15850630 (Pubitemid 40591691)
4. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386
5. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R, Am J Trop Med Hyg 2001 64 247 256 11463111
6. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Palacios PI, Am J Trop Med Hyg 2006 74 991 998 16760509 (Pubitemid 351627405)
7. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ, JAMA 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
8. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated malaria. Falade C, Makanga M, Premji Z, Ortmann CE, Stockmeyer M, de Palacios PI, Trans R Soc Trop Med Hyg 2005 99 459 467 10.1016/j.trstmh.2004.09.013 15837358 (Pubitemid 40521344)
9. Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Mutabingwa T, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ, Lancet 2005 365 1474 1480 10.1016/S0140-6736(05)66417-3 15850631 (Pubitemid 40591692)
10. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children < 5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial. Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, Bergqvist Y, Gil JP, Premji Z, Björkman A, Mårtensson A, Clin Infect Dis 2011 52 873 882 10.1093/cid/cir066 21427394
11. Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study. Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, Bergqvist Y, Gil JP, Premji Z, Mårtensson A, Malar J 2011 10 64 10.1186/1475-2875-10-64 21410954
12. Declining responsiveness of plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, Frühauf H, Schaub B, Pfeil J, Peshu J, Hanpithakpong W, Rippert A, Juma E, Tsofa B, Mosobo M, Lowe B, Osier F, Fegan G, Lindegårdh N, Nzila A, Peshu N, Mackinnon M, Marsh K, PLoS One 2011 6 26005 10.1371/journal.pone.0026005 22102856
13. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Borrmann S, Sallas WM, Machevo S, González R, Björkman A, Mårtensson A, Hamel M, Juma E, Peshu J, Ogutu B, Djimdé A, D'Alessandro U, Marrast AC, Lefèvre G, Kern SE, Trop Med Int Health 2010 15 434 441 20180933
14. The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence. Premji ZG, Abdulla S, Ogutu B, Ndong A, Falade CO, Sagara I, Mulure N, Nwaiwu O, Kokwaro G, Malar J 2008 7 244 10.1186/1475-2875-7-244 19032767
15. Clinical pharmacokinetics and pharmacodynamics of artemether- lumefantrine. White NJ, van Vugt M, Ezzet F, Clin Pharmacokinet 1999 37 105 125 10.2165/00003088-199937020-00002 10496300 (Pubitemid 29431479)
16. Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria. Kokwaro G, Mwai L, Nzila A, Expert Opin Pharmacother 2007 8 75 94 10.1517/14656566.8.1.75 17163809 (Pubitemid 46070831)
17. Antimalarial pharmacokinetics and treatment regimens. White NJ, Br J Clin Pharmacol 1992 34 1 10 1633062
18. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Van Vugt M, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, Luxemburger C, White NJ, Nosten F, Looareesuwan S, Am J Trop Med Hyg 1999 60 936 942 10403324 (Pubitemid 29296218)
19. Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Kabanywanyi AM, Lengeler C, Kasim P, King'eng'ena S, Schlienger R, Mulure N, Genton B, Malaria J 2010 9 48 10.1186/1475-2875-9-48
20. Coartem/Riamet Basic Prescribing Information. Novartis Pharma AG Last updated September 2007
21. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Abdulla S, Sagara I, Borrmann S, D'Alessandro U, González R, Hamel M, Ogutu B, Mårtensson A, Lyimo J, Maiga H, Sasi P, Nahum A, Bassat Q, Juma E, Otieno L, Björkman A, Beck HP, Andriano K, Cousin M, Lefèvre G, Ubben D, Premji Z, Lancet 2008 372 1819 1827 10.1016/S0140-6736(08)61492-0 18926569
22. Severe falciparum malaria. World Health Organization, Trans R Soc Trop Med Hyg 2000 94 1 S90 11103309
23. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, 2003 http://www.who.int/malaria/publications/atoz/whohtmrbm200350/en/ [Accessed June 22, 2008]
24. Pharmacokinetic and pharmacodynamic characteristics of artemether-lumefantrine dispersible tablet in African children with uncomplicated malaria. Djimdé AA, Tekete M, Abdulla S, Lyimo J, Bassat Q, Mandomando I, Lefèvre G, Borrmann S, Antimicrob Agents Chemother
25. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. Ashley EA, Stepniewska K, Lindegårdh N, McGready R, Annerberg A, Hutagalung R, Singtoroj T, Hla G, Brockman A, Proux S, Wilahphaingern J, Singhasivanon P, White NJ, Nosten F, Tropical Med Int Health 2007 12 201 208 10.1111/j.1365-3156. 2006.01785.x
26. Artemisinin Resistance in Cambodia 1 (ARC1) study consortium. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
27. Plasmodium falciparumclinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks. Rogier C, Ly AB, Tall A, Cissé B, Trape JF, Am J Trop Med Hyg 1999 60 410 420 10466970 (Pubitemid 29162124)
28. Clinical manifestations of severe malaria in the highlands of southwestern Uganda. Idro R, Bitarakwate E, Tumwesigire S, John CH, Am J Trop Med Hyg 2005 72 561 567 15891130 (Pubitemid 41278824)
29. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO, Malar J 2008 7 107 10.1186/1475-2875-7-107 18547416 (Pubitemid 352000602)
30. The burden of malaria in Africa. Samba EM, Afr Health 1997 19 17 12321237